Objective: Osteoarthritis (OA) is currently diagnosed using clinical and radiographic findings. In recent years magnetic resonance imaging (MRI) use in OA has increasingly been studied. This study was conducted to determine the diagnostic utility of MRI in OA through a meta-analysis of published studies. Methods: A systematic literature search was undertaken to include studies that used MRI to evaluate or detect OA. MRI was compared to various reference standards: histology, arthroscopy, radiography, CT, clinical evaluation, and direct visual inspection. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and receiver operating characteristic (ROC) area under the curve (AUC) were calculated. Random-effects models were used to pool results. Results: Of 20 relevant studies identified from the literature, 16 reported complete data and were included in the meta-analysis, with a total of 1220 patients (1071 with OA and 149 without). Overall sensitivity from pooling data of all the included studies was 61% [95% confidence interval (CI) 53e68], specificity was 82% (95% CI 77e87), PPV was 85% (95% CI 80e88), and NPV was 57% (95% CI 43e70). The ROC showed an AUC of 0.804. There was significant heterogeneity in the above parameters (I 2 > 83%).
Introduction
Osteoarthritis (OA) is a disease of the synovial joint tissues in which there is destruction of synovial joint tissues and active, but ineffective attempts at repair. 1 This structural change can lead to pain and disability. In fact, the risk for disability caused by OA is on par with that of cardiovascular disease and greater than that due to any other medical condition in the elderly. 2 Despite this, the aetiology and pathology of OA are not well understood. This contributes to the discrepancy between pathological evidence for the disease and clinical symptoms. 3 Because of this inconsistency, no single measure is used for diagnosis in OA, but rather a combination of tools, which yields better diagnostic performance than does any one of those tools on its own. Currently, the diagnosis of knee OA in the clinic is most often made using the 1986 criteria of the American College of Rheumatology. These criteria include a combination of the patient's age, signs and symptoms on physical exam, radiographic and/or laboratory evidence. 4 When the radiograph is used along with physical exam, the sensitivity and specificity of this method are 91% and 86%, respectively. Using a classification and regression tree technique (CART) with clinical, radiographic and laboratory evidence raises the sensitivity and specificity into the mid-eighty to mid-ninety percent range. 4 These diagnostic techniques are relatively inexpensive and readily available. More recently, The European League Against Rheumatism (EULAR) OA Task Force suggested that a confident clinical diagnosis of knee OA may be made according to three symptoms (persistent knee pain, morning stiffness and reduced function) and three signs (crepitus, restricted movement and bony enlargement). 5 Although the American
College of Rheumatology (ACR) or EULAR criteria remain the standard for diagnosis both in the clinic and in research, magnetic resonance imaging (MRI) has been increasingly used as well. 6 Before widespread use of MRI in clinical practice is adopted reasoned debate of the strengths and weaknesses of this method should be considered. Cost concerns, lack of clarity about diagnostic performance and little standardization regarding MRI interpretation has made it unclear whether this increased use of MRI in clinical practice is rational. In contrast to X-ray, MRI can visualize all tissues in the joint involved in OA: cartilage, menisci, bone, and soft tissue. In addition, MRI causes no ionizing radiation exposure. While it does not have the distortions and magnification problems inherent in radiographs, MRI does have its own motion and susceptibility artifacts. MRI also requires several different pulse sequences to visualize specific tissue types, and its use requires determining the best sequences for various features. Since 1988, numerous studies have examined the use of MRI in imaging synovial inflammation, meniscus pathology, cartilage morphology alteration, bone marrow lesions, osteophytes, cartilage composition, and other markers along with their correlation with clinically defined OA. 7 The predictive value and diagnostic performance of some of these markers have also been studied. 8, 9 One hope in testing the diagnostic utility of MRI in OA is to find and use some of those features undetectable by other imaging modalities, thus potentiating an earlier diagnosis of OA or a diagnosis of pre-osteoarthritis (pre-OA), in those patients lacking clinical symptoms. This would allow for therapeutic trials aimed at altering the preliminary course of OA and attempting to prevent many of the later degenerative changes which have already occurred once the disease is detected by clinical exam and radiographic change. Such an early diagnosis has not been possible with the current standard techniques discussed above. However a recent study has proposed a definition of OA based on MRI using the Delphi method in an attempt to move towards detecting earlier disease. 10 Despite the growing pool of information, there is little uniformity in the diagnostic application of MRI and a lack of its confirmed diagnostic utility, as noted in the "Evidence Based Recommendations for the Diagnosis of Knee OA" published by EULAR in 2009. 5 Over the last decade we have gained a better understanding of the many individual features on MRI, their clinical and pathologic significance, and how to use many of them quantitatively.
11 As yet however the diagnostic performance of MRI for OA has not been adequately studied. The objective of this meta-analysis was to evaluate, and determine the factors affecting, the diagnostic performance of MRI in the setting of OA.
Methods

Systematic literature search
An online literature search was conducted of the OVID MEDLINE (1945-), Embase (1980-), and Cochrane databases (1998-) of articles published up to the time of the search, April 2009, with the search entries "MRI", and "osteoarthritis", "osteoarthritides", "osteoarthrosis", "osteoarthroses", "degenerative arthritis", "degenerative arthritides", or "osteoarthritis deformans". The abstracts of the 1330 citations received with this search were then preliminarily screened for relevance by two reviewers (KH and DJH). For this preliminary search, all articles which used MRI, in some form, on patients with OA of the knee, hip, or hand were included. Although review articles were not included (see Inclusion/exclusion criteria), citations found in any review articles which were not already included in our preliminary search were screened for possible inclusion in this study. This added seven more relevant studies to our search. One further article was added by one of the authors of this meta-analysis bringing the preliminary total to 1338.
Inclusion/exclusion criteria
Only studies published in English were included. Studies presenting non-original data were excluded, such as reviews, editorials, opinion papers, or letters to the editor. Studies using non-human subjects or specimens were excluded. Studies in which rheumatoid, inflammatory, or other forms of arthritis were incorporated in the OA datasets were excluded, as well as general joint-pertinent MRI studies not focused on OA. Studies with no extractable, numerical data were excluded. Only those articles which had some measure of diagnostic performance were included. Any duplicates which came up in the preliminary search were excluded.
For the meta-analysis, only those articles from the systematic review were included that had complete sensitivity and specificity data needed to derive the true positive (TP), false positive (FP), true negative (TN), and false negative (FN) values for that study.
Data abstraction
Of the preliminary 1338 abstracts, 243 were selected for data abstraction of which 22 were pertinent to diagnostic performance (Fig. 1) . Two of these studies were excluded as they used MRI as the reference standard against which X-ray techniques were compared, 12,13 leaving 20 studies. Two reviewers (KH and LM)
independently abstracted the following data: (1) patient demographics and inclusion/exclusion criteria; (2) MRI make, sequences and techniques used, tissue types viewed; (3) study type and funding source; (4) MRI reliability/reproducibility data; (5) which diagnostic measures were used with MRI (e.g., cartilage thickness measurements, lesion identification, etc.) and their diagnostic performance (e.g., sensitivity, specificity, etc.) when compared with a reference standard; (6) the reference standard measures against which the MRI measure was evaluated; (7) treatment and MRI measures (when appropriate).
Assessment of study quality
Quality and bias assessment of the studies was performed using the Downs Methodological Study Criteria. 14 
Outcome measures
The focus of this analysis was on diagnostic performance. Data extracted on the diagnostic performance of MRI or material pertaining to defining OA on MRI was used. The ability of MRI to discriminate between patients with and without OA (OA in this case is defined by either clinical diagnosis, radiography, or both) was summarized by sensitivity, specificity, positive and negative predictive values (PPV, NPV), positive and negative likelihood ratios (LRþ, LRÀ) and accuracy. A LRþ above 10 or LRÀ below 0.1 is considered strong evidence to respectively rule in or rule out a diagnosis in most circumstances. The term "overall sensitivity" (or specificity, etc.) is used to describe the results from pooling of all the TP, FP, TN, FN data gathered from the studies included, regardless of the reference standard and tissue type used.
Data analysis
The TP, FP, TN, FN values were derived from the sensitivity and specificity data and from the numbers of subjects reported in each study. From these the point estimates and their 95% confidence intervals (CIs) of the sensitivity, specificity, PPV, and NPV were calculated. Positive and negative likelihood ratios were computed using the standard formulas: LRþ ¼ sensitivity/(1Àspecificity) and LRÀ ¼ specificity/(1Àsensitivity). The area under the receiver operating characteristic (ROC) curve or AUC was also calculated. ROC presents a curve of sensitivity (y-axis) against 1Àspecificity (x-axis) at different cut-off points (e.g., deciles) of the MRI measures. ROC quantifies the overall ability of a diagnostic test to classify diseased and non-diseased individuals correctly. Larger values of ROC (range between 0 and 1) indicate good discriminative power. 15 The DerSimonian and Laird method 16 for random-effects models was used to pool individual estimates. Heterogeneity was assessed across the studies using the Cochran Q statistic and inconsistency, I 2 which represents the percent variance across all studies attributable to heterogeneity rather than to chance; a higher value indicates more heterogeneity. 17 Random-effects models and inconsistency were calculated for the sub-groups of histology, arthroscopy, and X-ray as reference standards. Statistical significance was set at 0.05 and CIs calculated at 95%.
Results
We identified 20 studies which met our inclusion criteria and contained relevant diagnostic measure and performance data. 8,9,18e35 Study attributes and population characteristics are presented in Table I . The studies included a total of 1559 patients, 1396 with OA and 163 without OA. A large majority of the studies used semiquantitative MRI measurement techniques for measuring OA (Table II) . Various tissues were imaged in the different studies. Cartilage was examined in the majority of studies (16 studies, Table II ). The other commonly viewed tissue types were meniscus (eight), synovium (two), bone (three), and bone marrow lesions (three). As the reference standard measure against which the MRI diagnostic techniques were compared, arthroscopy was used most prevalently, followed by histological section and X-ray (Table III) . Sixteen of the original 20 papers were included in the metaanalysis because four lacked complete sensitivity and specificity data needed to derive the TP, FP, TN, FN data. 8, 24, 25, 35 A total of 1220 patients were included in the meta-analysis, 1071 with OA and 149 without OA. In five of the 16 studies more than one parameter was analysed (e.g., tissue type, defined endpoint) which created separate datasets in our analyses. 9, 21, 22, 29, 33 Overall sensitivity of all the datasets from the random-effects model was 61% (95% CI 53e68) (Fig. 2) , specificity from the random-effects model was 82% (95% CI 77e87) (Fig. 3) , PPV was 85% (95% CI 80e88), and NPV 57% (95% CI 43e70; Table IV ). LRþ was 3.22 (95% CI 2.33e4.45) and LRÀ was 0.48 (95% CI 0.40e0.59). Overall accuracy was 69% (95% CI 61e76). An ROC curve showed an area under the curve (AUC) of 0.804 (Fig. 4) . There was significant heterogeneity in all of the parameters listed above (I 2 > 83%). Consistent with this, the funnel plots including all the data show marked variability for individual point estimates, more so with sensitivity than specificity (Figs. 5 and 6 ). The diagnostic performance of MRI varied markedly depending on which reference standard it was compared to. In general the MRI sensitivity was better when it was compared to the tissue of interest directly (e.g., arthroscopy, histology, open inspection) as distinct from X-ray and clinical information, whereas specificity was superior with arthroscopy, worst with open inspection, with histology and X-ray in between. Using histology as the reference standard the sensitivity increases to 74% (95% CI 65e81) while the specificity decreases to 76% (95% CI 67e82; Table V ). Sensitivity and specificity are comparable to the overall values when using radiography as the reference standard (Table VI) . With arthroscopy as the reference standard, both sensitivity and specificity increase to 69% (95% CI 62e75) and 93% (95% CI 86e96), respectively (Table VII) . When using only the clinical information as the reference standard, specificity is slightly decreased to 73% (95% CI 64e80), while sensitivity is markedly decreased to 39% (95% CI 26e54). Lastly, with open visual inspection of the tissues as reference standard the sensitivity increases to 86% (CI 65e96), while the specificity drops to 56% (CI 15e91).
The agreement for assessing bias by the data extraction readers was kappa ¼ 0.70.
Discussion
This study examines the diagnostic performance of MRI in OA compared with other clinical and research reference standards for viewing synovial joint structural change. The comparative reference standards have themselves relative merits when used for testing MRI techniques. Firstly, arthroscopy and histology, because they view cartilage and other joint tissues directly, are most suitable for judging the performance of MRI in imaging cartilage changes or meniscal degeneration. However, viewing cartilage defects directly may or may not correlate with actual clinical OA diagnosis. X-ray, on the other hand, cannot view cartilage directly, but provides an indirect representation of cartilage integrity through assessment of joint space width. This provides a poor reference standard with which to grade cartilage defects, as a lack of change in joint space width does not preclude possible cartilage defects on MRI.
8 X-ray also visualizes osteophytes, changes in bone contour and sclerosis. Because the KellgreneLawrence scale is comprised of these four characteristics and has been used in OA definition, correlation with radiographic findings could lend utility to MRI in OA diagnosis. The specificity is generally superior to sensitivity for nearly all datasets in the studies included, suggesting that, based on the MRI features used, MRI would be more useful in ruling out false positives when a patient is already suspected of having OA by other measures. However, because current diagnosis is performed with clinical and radiologic means, until there is a separate, well-validated MRI-based definition of OA, only those diagnostic measures based on reference standards of arthroscopic or histologic definitions of OA can add to a diagnosis made with the present diagnostic standards.
Not surprisingly, diagnostic performance, and more precisely sensitivity is better with arthroscopy and histology as reference standards compared with X-ray because they directly visualize cartilage, as does MRI. Because of its lower sensitivity compared to ACR clinical criteria as measured by even the more robust reference standards (e.g., arthroscopy and histology), MRI is not currently useful as a preliminary screen for identifying new cases of OA. Its lack of utility in this case is especially clear given that for OA of the knee the much cheaper, presently-used diagnostic tools of history, exam, and radiography provide a better sensitivity: radiograph plus physical exam at 91% and the CART from mid-eighty to mid-ninety percent. 4 In providing more clinical utility, likelihood ratios >10
and <0.1 are needed for strong evidence in respectively ruling in or out a diagnosis, and most of those found in this study are far from providing such support for a diagnosis either way. 36 A wellvalidated MRI-based definition of OA is needed before it can supersede the current methods of diagnosis, and for this the correct constellation of MRI features must be found to raise the sensitivity and specificity of this imaging modality. Radiography is currently used as a confirmatory finding in the clinical diagnosis of OA, as well as to rule out other possible diagnoses when a thorough history and physical exam proves ambiguous. Even if MRI had the needed sensitivity to detect early OA before it appears symptomatically in the clinic, or if it could inform us on the stage of the disease from an anatomical or pathological standpoint, it would still provide no therapeutic advantage as there are currently no available disease-modifying therapies for OA. In addition MRI carries with it a large cost; an MRI of the knee costs approximately 5e22 times that of a standard radiograph in many health care settings. 37, 38 Given the prevalence of OA in the general population, use of MRI in this setting would come at a great expense. The only setting in which the use of MRI may be beneficial is in cases in which other diseases are high on the differential, and they can be ruled out on MRI, or treated if present, e.g., early stage avascular necrosis. Any argument for MRI use in OA diagnosis needs to show a clear therapeutic benefit to make up for the large escalation in cost. There were clearly some limitations to this study. The many different MRI sequences used, the different tissues used, and the various reference standards limit the usefulness and meaningfulness of any single value for sensitivity, specificity, PPV, NPV, LRþ, and LRÀ. Ideally the many studies would have used the same parameters, tissue types and MRI sequences, to obtain a more powerful and homogeneous diagnostic value. In addition, the studies examined each had variations in the severity of OA included, affecting their diagnostic measurements; it was beyond the scope of this analysis to draw distinctions between degrees of OA and the effect of these gradations on MRI performance. More than half of the studies assessed joint regions or counted the number of total defects noted rather than numbers of total joints or numbers of patients. 18e20, 23, 26, 28, 29, 31, 33, 34 This skewed the weight of each datapoint in the meta-analysis; ideally all of the studies would have one datapoint per subject, or an equal number of surfaces analysed per subject. Due to the number of existing studies fulfilling the inclusion criteria found in our search and their differing approaches, the conclusions we can draw about detailed aspects of OA diagnosis have limitations. In current clinical practice, diagnostic needs which MRI could theoretically fill are in differential diagnosis (e.g., avascular necrosis), differentiation of OA into subcategories/ phenotypes, and in diagnosing a pre-OA state, i.e., identifying structural change in patients with no symptoms or in those with symptoms but lacking structural changes on radiograph. As this review is focused on studies comparing the diagnostic performance of MRI in detecting OA with other standards of reference, the studies included do not address the question of an expanded differential diagnosis nor creating subcategories of OA. Reichenbach et al. assess bone attrition on radiograph 13 which could be included in diagnosing pre-OA, and which has already been found to be a potential target of therapy 39 . However, this was only one study and not enough to draw larger conclusions from about pre-OA diagnosis.
An important step in developing disease-modifying treatments is to create clear and validated classification criteria for the diagnosis of a pre-OA state. Pre-OA is defined as the state before clinical symptoms, or conventional radiologic markers of OA appear, but in a patient who will progress to fully developed OA. Clearly such a state cannot be defined with current diagnostic definitions of OA, but can only be detected with newer markers, radiologic, histologic, or otherwise. Possible evidence of this state has already been found histologically. 40 Detection of pre-OA could be demonstrated by a prognostic study looking at various clinical and imaging features at baseline and following them longitudinally to ascertain if disease occurs. These markers, which may or may not seem useful currently, could then be measured for diagnostic usefulness against a clinical endpoint years later, such as total knee arthroplasty. Those markers which demonstrate better predictive validity could potentiate a new, MRI-based definition of pre-OA in the future. The capability to designate patients as pre-OA and likewise to follow pre-OA disease activity, would allow testing of disease-modifying therapies in this earlier, and hopefully more easily-altered, stage of the disease. This analysis found that MRI has some potential as a noninvasive method of visualizing OA when compared with standard radiograph, histology, gross dissection and other techniques. Based on currently described MRI features of OA, MRI has more utility in ruling out OA when otherwise suspected, than in detecting new OA. However, with an overall sensitivity below that of clinical and radiographic diagnosis and with these more cost-effective diagnostic tools currently used in the clinic there would seem to be no indication for using MRI in routine clinical diagnosis at this time. Given the current lack of disease-modifying therapeutic options available for treating OA and the lack of validated classification criteria for diagnosing early OA, MRI should not be used in a clinical setting for diagnosis of OA.
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